secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-09-04T21:25:28+00:00
Accession:  0001140361-26-035809
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology amends $6M promissory note with YA II PN, adding mandatory redemption and extended cure period
--------------------------------------------------------------------------------

- Amendment to $6,000,000 promissory note dated June 15, 2026 with YA II PN, Ltd.
- Requires weekly remittance notices for ATM proceeds and payment within 1 business day.
- Extends Nasdaq listing deficiency cure period from 75 to 180 days.
- New provision: 100% of net cash proceeds from non-ATM equity financings must be paid to holder within 5 business days.
- Effective upon full payment of September 14, 2026 installment amount.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126035809/0001140361-26-035809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126035809/ef20081442_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-035809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer